News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
310 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (8944)
Month
January (2936)
February (2969)
March (2710)
April (2908)
May (3626)
June (2409)
July (2088)
August (2590)
September (2381)
October (3064)
November (3189)
December (2222)
Day
1 (184)
2 (142)
5 (163)
6 (107)
7 (310)
8 (241)
9 (171)
12 (212)
13 (134)
14 (258)
15 (266)
16 (111)
19 (118)
20 (145)
21 (149)
22 (140)
23 (132)
26 (20)
27 (147)
28 (183)
29 (187)
30 (105)
31 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
31
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery showed statistically significant and clinically meaningful improvement in pathologic complete response in high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11
May 7, 2025
·
19 min read
Press Releases
InflaRx Reports First Quarter 2025 Financial Results and Provides Business Update
May 7, 2025
·
24 min read
Press Releases
CervoMed to Participate in H.C. Wainwright 3rd Annual BioConnect Investor Conference
May 7, 2025
·
1 min read
Press Releases
Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference
May 7, 2025
·
1 min read
Press Releases
Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update
May 7, 2025
·
8 min read
Press Releases
BridgeBio to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 2025
May 7, 2025
·
1 min read
Press Releases
Repligen Corporation to Present at Upcoming May 2025 Investor Conferences
May 7, 2025
·
1 min read
Press Releases
Orogen Therapeutics Announces Expansion of Board with Biopharma Leaders Mikael Dolsten and Dieter Weinand as Independent Non-Executive Directors.
May 7, 2025
·
7 min read
Press Releases
New Data Show Delve Bio’s Metagenomic Platform Accurately Identifies Viruses and Their Subtypes With a Single Test
May 7, 2025
·
3 min read
Press Releases
Arrowhead Pharmaceuticals to Participate in May 2025 Investor Conferences
May 7, 2025
·
4 min read
Previous
22 of 31
Next
